0.00Open0.15Pre Close0 Volume618 Open Interest54.00Strike Price0.00Turnover6845.01%IV13.33%PremiumDec 6, 2024Expiry Date0.00Intrinsic Value100Multiplier-4DDays to Expiry0.15Extrinsic Value100Contract SizeAmericanOptions Type0.1690Delta0.1494Gamma318.53Leverage Ratio-2627.1209Theta0.0000Rho53.84Eff Leverage0.0001Vega
CRISPR Therapeutics Stock Discussion
-TSLA
-PLTR
-SQ
were sold out in the last 10 days.
But, the institution also bought back some of
+COIN
+Amazon
+ILMN
+Meta
at lower price.
But on Nov 6, they bought back 1 Billion worth of TSLA at +/- 281 $ and 468 Million worth of PLTR stock at +/- 55$ back in their portfolio...
(Probably FOMO for PLTR or ...
Most of Wallstreet and retail investors don't understand Crispr and most see it as a very risky stock to invest in but once it begins rolling out its cures and making obscene amounts of cash..Along with license agreements to other companies Crispr Theraputics share price will rise significantly. ...
$ONEOK Inc (OKE.US)$ : “I think Oneok is terrific. I would indeed buy more.”
$DexCom (DXCM.US)$ : “Dexcom had a real bad miss. They still really haven’t fully explained why that is...I’d stay away from De...
No comment yet